Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 32.00
+0.40 (1.27%)
At close: Nov 28, 2025
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 1.25 billion as of November 28, 2025. Its market cap has increased by 18.04% in one year.
Market Cap
1.25B
Enterprise Value
1.24B
Revenue
103.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.00
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 1.25B, a decrease of -61.44%. That is a compound annual growth rate of -9.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 1.25B | 55.52% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | 66.24M | 20.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 263.32B |
| Novartis AG | 200.48B |
| Lonza Group AG | 38.63B |
| Galderma Group AG | 37.98B |
| Alcon | 31.37B |
| Sandoz Group AG | 24.43B |
| Straumann Holding AG | 14.61B |
| Sonova Holding AG | 11.93B |